동부말뇌염 : 파이프라인 리뷰

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

동부말뇌염은 모기가 매개가 되는 감염증으로, 아르보바이러스인 동부말뇌염 바이러스가 원인입니다. 발열, 두통 등의 가벼운 증상을 비롯해 착란, 혼수 등 심각한 증상에 이르기까지 폭넓은 증상이 나타납니다.

동부말뇌염(Eastern Equine Encephalitis) 치료제의 개발 상황에 대해 조사 분석했으며, 파이프라인 제품 개요, 임상 단계별 제품 개요, 주요 기업 개요, 치료제 개요, 파이프라인 제품의 최신 동향, 최신 뉴스와 프레스 릴리스 등의 정보를 전해드립니다.

목차

서론

동부말뇌염 개요

치료제 개발

• 파이프라인 제품 : 개요
• 파이프라인 제품 : 비교 분석

개발중인 치료제 : 기업별

조사중인 치료제 : 대학/연구소별

파이프라인 제품 개요

• 임상 단계 제품
• 초기 단계 제품

개발중인 제품 : 기업별

조사중인 제품 : 대학/연구소별

치료제 개발에 참여하고 있는 기업

• AlphaVax, Inc.
• AltraVax Inc.
• EpiVax, Inc.
• Profectus BioSciences, Inc.

치료제 평가

• 단독치료 제품(Monotherapy Products)별
• 표적별
• 작용기서별
• 분자 종류별

치료제 개요

• equine encephalitis vaccine
• equine encephalitis vaccine
• equine encephalitis vaccine
• equine encephalitis vaccine
• TSI-GSD-104

개발 휴지중인 프로젝트

부록

도표

List of Tables

List of Tables

• Number of Products under Development for Eastern Equine Encephalitis, 2021
• Number of Products under Development by Companies, 2021
• Number of Products under Development by Universities/Institutes, 2021
• Products under Development by Companies, 2021
• Products under Development by Universities/Institutes, 2021
• Number of Products by Stage and Target, 2021
• Number of Products by Stage and Mechanism of Action, 2021
• Number of Products by Stage and Route of Administration, 2021
• Number of Products by Stage and Molecule Type, 2021
• Eastern Equine Encephalitis - Pipeline by AlphaVax Inc, 2021
• Eastern Equine Encephalitis - Pipeline by Auro Vaccines LLC, 2021
• Eastern Equine Encephalitis - Pipeline by Bavarian Nordic A/S, 2021
• Eastern Equine Encephalitis - Pipeline by Merck & Co Inc, 2021
• Eastern Equine Encephalitis - Dormant Projects, 2021

List of Figures

List of Figures

• Number of Products under Development for Eastern Equine Encephalitis, 2021
• Number of Products under Development by Companies, 2021
• Number of Products under Development by Universities/Institutes, 2021
• Number of Products by Targets, 2021
• Number of Products by Stage and Targets, 2021
• Number of Products by Mechanism of Actions, 2021
• Number of Products by Stage and Mechanism of Actions, 2021
• Number of Products by Routes of Administration, 2021
• Number of Products by Stage and Routes of Administration, 2021
• Number of Products by Molecule Types, 2021
• Number of Products by Stage and Molecule Types, 2021

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Eastern Equine Encephalitis - Drugs In Development, 2021, provides an overview of the Eastern Equine Encephalitis (Infectious Disease) pipeline landscape.

Eastern equine encephalitis is a disease caused by a zoonotic mosquito vectored Togavirus that is present in North, Central, and South America, and the Caribbean. Eastern equine encephalitis (EEE) is an extremely rare and often fatal infection that causes encephalitis or inflammation of the brain. It is spread by the bite of a mosquito infected with EEE virus (EEEV). Severe cases of EEE infection begin with the sudden onset of headache, high fever, chills, and vomiting that may progress into disorientation, seizures, encephalitis (inflammation of the brain), and coma.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Eastern Equine Encephalitis - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Eastern Equine Encephalitis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Eastern Equine Encephalitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Eastern Equine Encephalitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I and Preclinical stages are 1 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 1, 1 and 3 molecules, respectively.

Eastern Equine Encephalitis (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

• The pipeline guide provides a snapshot of the global therapeutic landscape of Eastern Equine Encephalitis (Infectious Disease).
• The pipeline guide reviews pipeline therapeutics for Eastern Equine Encephalitis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Eastern Equine Encephalitis (Infectious Disease) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Eastern Equine Encephalitis (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Eastern Equine Encephalitis (Infectious Disease)

Reasons to Buy:

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Eastern Equine Encephalitis (Infectious Disease).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Eastern Equine Encephalitis (Infectious Disease) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents

List of Tables

List of Figures

• Introduction
• Global Markets Direct Report Coverage
• Eastern Equine Encephalitis - Overview
• Eastern Equine Encephalitis - Therapeutics Development
• Pipeline Overview
• Pipeline by Companies
• Pipeline by Universities/Institutes
• Products under Development by Companies
• Products under Development by Universities/Institutes
• Eastern Equine Encephalitis - Therapeutics Assessment
• Assessment by Target
• Assessment by Mechanism of Action
• Assessment by Route of Administration
• Assessment by Molecule Type
• Eastern Equine Encephalitis - Companies Involved in Therapeutics Development
• Eastern Equine Encephalitis - Drug Profiles
• Eastern Equine Encephalitis - Dormant Projects
• Eastern Equine Encephalitis - Product Development Milestones
• Featured News & Press Releases
• Apr 18, 2019: UofL researcher developing drug to treat emerging encephalitis viruses
• Jan 24, 2019: Bavarian Nordic advances development of equine encephalitis virus vaccine
• Dec 09, 2015: Profectus BioSciences Receives $4.6 Million DOD Grant to Develop Vaccine for Western, Eastern, and Venezuelan Equine Encephalitis Viruses
• Appendix
• Methodology
• Coverage
• Secondary Research
• Primary Research
• Expert Panel Validation
• Contact Us
• Disclaimer